DELCATH SYSTEMS, INC.

For the period ended Mar 31, 2025. Filed May 8, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 8, 2025

DCTH$20.27+35.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 1. Financial Statements

Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

	March 31,2025	December 31,2024
Assets
Current assets
Cash and cash equivalents	$12,776	$32,412
Short-term investments	46,120	20,821
Accounts receivable	13,942	10,890
Inventories	7,132	6,933
Prepaid expenses and other current assets	4,379	2,704
Total current assets	84,349	73,760
Property, plant and equipment, net	1,954	1,790
Right-of-use assets	1,016	1,039
Total assets	$87,319	$76,589
Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable	$1,619	$961
Accrued expenses	3,558	5,078
Lease liabilities, current	110	105
Total current liabilities	5,287	6,144
Lease Liabilities, non-current	906	933
Other liabilities, non-current	896	766
Total liabilities	$7,089	$7,843
Commitments and contingencies (see Note 12)
Stockholders’ equity
Preferred stock, $0.01 par value; 10,000,000 shares authorized; 14,192 and 14,192 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	—	—
Common stock, $0.01 par value; 80,000,000 shares authorized; 33,436,612 shares and 33,061,002 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	334	331
Additional paid-in capital	609,994	599,881
Accumulated deficit	(530,479)	(531,548)
Accumulated other comprehensive income	381	82
Total stockholders’ equity	80,230	68,746
Total liabilities and stockholders’ equity	$87,319	$76,589

Condensed Consolidated Statements of Operations and Comprehensive Income and Loss

(in thousands, except share and per share data)

	Three months ended March 31,
	2025	2024
Product revenue	$19,784	$3,139
Cost of goods sold	(2,845)	(903)
Gross profit	16,939	2,236
Operating expenses:
Research and development expenses	5,007	3,700
Selling, general and administrative expenses	11,290	8,814
Total operating expenses	16,297	12,514
Operating gain (loss)	642	(10,278)
Change in fair value of warrant liability	—	(612)
Interest income (expense), net	618	(199)
Other income (expense)	4	(22)
Income (loss) before income taxes	1,264	(11,111)
Income tax expense	195	—
Net income (loss)	1,069	(11,111)
Other comprehensive income (loss):
Unrealized gain on investments adjustments	239	8
Foreign currency translation adjustments	60	14
Total comprehensive income (loss)	$1,368	$(11,089)
Common share data:
Basic income (loss) per common share	$0.03	$(0.45)
Weighted average number of basic shares outstanding	34,642,641	24,887,180
Diluted income (loss) per common share	$0.03	$(0.45)
Weighted average number of dilutive shares outstanding	39,511,120	24,887,180

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.